Health Professional Radio - Podcast

Dr. Dave Anderson, Chief Scientific Officer at VBI Vaccines discusses the company's work to develop a pan-coronavirus vaccine to address mutations. He talks about the public health implications of a mutation of COVID-19. In addition to COVID, VBI Vaccines is in late-stage development of the only potential vaccine that mimics all three surface antigens of the hepatitis B virus.